(Q54456938)

30 May 2018

title

Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer. (English)

1 reference

30 May 2018

8

Kiyo Torii

1 reference

30 May 2018

Sadamu Noda

9

object named as

Sadamu Noda

1 reference

30 May 2018

Eisaku Toji

4

object named as

Eisaku Toji

1 reference

30 May 2018

Shinji Izuma

6

object named as

Shinji Izuma

1 reference

30 May 2018

author name string

Osamu Nunobiki

1

1 reference

30 May 2018

Masatsugu Ueda

2

1 reference

30 May 2018

Michiko Yamamoto

3

1 reference

30 May 2018

Naomi Sato

5

1 reference

30 May 2018

Yoshiaki Okamoto

7

1 reference

30 May 2018

publication date

1 November 2009

1 reference

30 May 2018

published in

Human Cell

1 reference

30 May 2018

volume

22

1 reference

30 May 2018

issue

4

1 reference

30 May 2018

page(s)

101-106

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1111/j.1749-0774.2009.00075.x

exact match

0 references

cites work

Primary structure polymorphism at amino acid residue 72 of human p53.

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2009.00075.X

Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2009.00075.X

Progressive derailment of cell cycle regulators in endometrial carcinogenesis.

21 January 2018

1 reference

12 December 2020

Regulation of p53 function

1 reference

12 December 2020

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis

1 reference

12 December 2020

Genetic association studies in digestive system malignancies.

1 reference

12 December 2020

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

1 reference

12 December 2020

p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer

1 reference

12 December 2020

Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer.

1 reference

12 December 2020

Different trends of p53, MDM2 and p14 ARF expression patterns in endometrial adenocarcinomas versus hyperplasia

1 reference

12 December 2020

Association of breast cancer outcome with status of p53 and MDM2 SNP309

1 reference

12 December 2020

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

1 reference

12 December 2020

Regulation of p53 stability by Mdm2

1 reference

12 December 2020

Codon 72 polymorphism of the TP53 gene

1 reference

12 December 2020

Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas

1 reference

12 December 2020

Germline polymorphism of cancer susceptibility genes in gynecologic cancer

1 reference

12 December 2020

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

1 reference

12 December 2020

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium

1 reference

12 December 2020

Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma.

1 reference

12 December 2020

MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population

1 reference

12 December 2020

Glutathione S-transferase GSTM1, GSTT1 and p53 codon 72 polymorphisms in human tumor cells

1 reference

12 December 2020

P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women.

1 reference

12 December 2020

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.

1 reference

12 December 2020

MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C

1 reference

12 December 2020

MDM2 SNP309 is associated with endometrial cancer risk

1 reference

12 December 2020

10.1111/J.1749-0774.2009.00075.X

Identifiers

DOI

1 reference

30 May 2018

Dimensions Publication ID

0 references

1 reference

30 May 2018